Displaying all 10 publications

Abstract:
Sort:
  1. Ibrahim HH, Singh MSJ, Al-Bawri SS, Islam MT
    Sensors (Basel), 2020 May 13;20(10).
    PMID: 32414069 DOI: 10.3390/s20102772
    The investigation into new sources of energy with the highest efficiency which are derived from existing energy sources is a significant research area and is attracting a great deal of interest. Radio frequency (RF) energy harvesting is a promising alternative for obtaining energy for wireless devices directly from RF energy sources in the environment. An overview of the energy harvesting concept will be discussed in detail in this paper. Energy harvesting is a very promising method for the development of self-powered electronics. Many applications, such as the Internet of Things (IoT), smart environments, the military or agricultural monitoring depend on the use of sensor networks which require a large variety of small and scattered devices. The low-power operation of such distributed devices requires wireless energy to be obtained from their surroundings in order to achieve safe, self-sufficient and maintenance-free systems. The energy harvesting circuit is known to be an interface between piezoelectric and electro-strictive loads. A modern view of circuitry for energy harvesting is based on power conditioning principles that also involve AC-to-DC conversion and voltage regulation. Throughout the field of energy conversion, energy harvesting circuits often impose electric boundaries for devices, which are important for maximizing the energy that is harvested. The power conversion efficiency (PCE) is described as the ratio between the rectifier's output DC power and the antenna-based RF-input power (before its passage through the corresponding network).
  2. Chung EL, Abdullah FF, Ibrahim HH, Marza AD, Zamri-Saad M, Haron AW, et al.
    Microb Pathog, 2016 Feb;91:141-54.
    PMID: 26706347 DOI: 10.1016/j.micpath.2015.12.003
    Haemorrhagic septicaemia is a disease caused by Pasteurella multocida serotype B: 2 and E: 2. The organism causes acute, highly fatal septicaemic disease with high morbidity and mortality in cattle and more susceptible in buffaloes. Lipopolysaccharide can be found on the outer cell wall of the organism. Lipopolysaccharide is released during multiplication which leads to inflammatory reaction. It represents the endotoxin of P. multocida type B: 2 and responsible for toxicity in haemorrhagic septicaemia which plays an important role in the pathogenesis of the disease. Therefore, the aim of this study was to investigate the clinical signs, blood parameters, gross post mortem lesions and histopathology changes caused by P. multocida type B:2 immunogen lipopolysaccharide infections initiated through intravenous and oral routes of infection. 9 buffalo heifers were divided equally into 3 treatment groups. Group 1 was inoculated orally with 10 ml of phosphate buffer saline (PBS); Group 2 and 3 were inoculated with 10 ml of lipopolysaccharide broth intravenously and orally respectively. For the clinical signs, there were significant differences (p < 0.05) in temperature between the control, intravenous and oral group. In hematology and biochemistry findings, there were significant differences (p < 0.05) in erythrocytes, haemoglobin, PCV, MCV, lymphocytes, monocytes, eosinophils, GGT and albumin between the control, intravenous and oral group. However, there were no significant differences (p > 0.05) in the MCHC, leukocytes, band neutrophils, basophils, thrombocytes, plasma protein, icterus index, total protein, globulin and A:G ratio between intravenous and oral group. For Group 2 buffaloes, there were gross lesions in the lung, trachea, heart, liver, spleen, and kidney. In contrast, lesions were only observed in the lung, trachea and liver of Group 3 buffaloes. There were significant differences (p < 0.05) in hemorrhage and congestion; necrosis and degeneration; and inflammatory cells infiltration between experimental groups and control group. However, there were no significant differences (p > 0.05) in edema lesion between groups. In conclusion, this study is a proof that oral route infection of P. multocida type B:2 immunogen lipopolysaccharide can be used to stimulate host cell responses where oral vaccine through feed could be developed in the near future.
  3. Ibrahim SK, Singh MJ, Al-Bawri SS, Ibrahim HH, Islam MT, Islam MS, et al.
    Nanomaterials (Basel), 2023 Jan 28;13(3).
    PMID: 36770483 DOI: 10.3390/nano13030520
    Massive multiple-input multiple-output (mMIMO) is a wireless access technique that has been studied and investigated in response to the worldwide bandwidth demand in the wireless communication sector (MIMO). Massive MIMO, which brings together antennas at the transmitter and receiver to deliver excellent spectral and energy efficiency with comparatively simple processing, is one of the main enabling technologies for the upcoming generation of networks. To actualize diverse applications of the intelligent sensing system, it is essential for the successful deployment of 5G-and beyond-networks to gain a better understanding of the massive MIMO system and address its underlying problems. The recent huge MIMO systems are highlighted in this paper's thorough analysis of the essential enabling technologies needed for sub-6 GHz 5G networks. This article covers most of the critical issues with mMIMO antenna systems including pilot realized gain, isolation, ECC, efficiency, and bandwidth. In this study, two types of massive 5G MIMO antennas are presented. These types are used depending on the applications at sub-6 GHz bands. The first type of massive MIMO antennas is designed for base station applications, whereas the most recent structures of 5G base station antennas that support massive MIMO are introduced. The second type is constructed for smartphone applications, where several compact antennas designed in literature that can support massive MIMO technology are studied and summarized. As a result, mMIMO antennas are considered as good candidates for 5G systems.
  4. Chung ELT, Abdullah FFJ, Marza AD, Saleh WMM, Ibrahim HH, Abba Y, et al.
    Microb Pathog, 2017 Jan;102:89-101.
    PMID: 27894962 DOI: 10.1016/j.micpath.2016.11.015
    The aim of this study was to investigate the clinico-pathology and haemato-biochemistry alterations in buffaloes inoculated with Pasteurella multocida type B:2 immunogen outer membrane protein via subcutaneous and oral routes. Nine buffalo heifers were divided equally into 3 treatment groups. Group 1 was inoculated orally with 10 mL of phosphate buffer saline (PBS); Group 2 and 3 were inoculated with 10 mL of outer membrane protein broth subcutaneously and orally respectively. Group 2 buffaloes showed typical haemorrhagic septicaemia clinical signs and were only able to survive for 72 h of the experiment. However, Group 3 buffaloes were able to survive throughout the stipulated time of 21 days of experiment. There were significant differences (p  0.05) in edema between groups except for the lung. This study was a proof that oral route infection of Pasteurella multocida type B:2 immunogen outer membrane protein can be used to stimulate host cell.
  5. Chung EL, Abdullah FF, Adamu L, Marza AD, Ibrahim HH, Zamri-Saad M, et al.
    Vet World, 2015 Jun;8(6):783-92.
    PMID: 27065648 DOI: 10.14202/vetworld.2015.783-792
    Pasteurella multocida a Gram-negative bacterium has been identified as the causative agent of many economically important diseases in a wide range of hosts. Hemorrhagic septicemia is a disease caused by P. multocida serotype B:2 and E:2. The organism causes acute, a highly fatal septicemic disease with high morbidity and mortality in cattle and more susceptible in buffaloes. Therefore, the aim of this study was to investigate the clinical signs, blood parameters, post mortem and histopathology changes caused by P. multocida Type B:2 infections initiated through the oral and subcutaneous routes.
  6. Marza AD, Jesse FF, Ahmed IM, Teik Chung EL, Ibrahim HH, Zamri-Saad M, et al.
    Microb Pathog, 2016 Apr;93:111-9.
    PMID: 26850845 DOI: 10.1016/j.micpath.2016.01.025
    Haemorrhagic septicaemia (HS) is an acute, fatal, septicaemic disease of cattle and buffaloes caused by one of two specific serotypes of Pasteurella multocida B:2 and E:2 in Asian and African, respectively. It is well known that HS affect mainly the respiratory and digestive tracts. However, involvement of the nervous system in pathogenesis of HS has been reported in previous studies without details. In this study, nine buffalo calves of 8 months old were distributed into three groups. Animals of Group 1 and 2 were inoculated orally and subcutaneously with 10 ml of 1 × 10(12) cfu/ml of P. multocida B:2, respectively, while animals of Group 3 were inoculated orally with 10 ml of phosphate buffer saline as a control. All calves in Group 1 and Group 3 were euthanised after 504 h (21 day) post-infection, while calves in Group 2 had to euthanise after 12 h post-infection as they develop sever clinical signs of HS. Significant differences were found in Group 2 in the mean scores of clinical signs, gross and histopathological changes which mainly affect different anatomic regions of the nervous system. In addition, successful bacterial isolation of P. multocida B:2 were obtained from different sites of the nervous system. On the other hand, less sever, clinical, gross and histopathological changes were found in Group 1. These results provide for the first time strong evidence of involving of the nervous system in pathogenesis of HS, especially in the peracute stage of the disease.
  7. Chung ELT, Jesse FFA, Marza AD, Ibrahim HH, Abba Y, Zamri-Saad M, et al.
    Trop Anim Health Prod, 2019 Jul;51(6):1773-1782.
    PMID: 30919320 DOI: 10.1007/s11250-019-01870-w
    Sudden death is usually the main finding in field animals during haemorrhagic septicaemia outbreaks caused by Pasteurella multocida type B:2 that causes acute, fatal and septicaemic disease in cattle and buffaloes. This situation may be due to failure in early detection of the disease where early treatment of antibiotics may improve the prognosis of the animal and other surviving animals. Thus, there is a grey area on the knowledge on the potential usage of pro-inflammatory cytokines and acute phase proteins as early biomarkers in the diagnosis of haemorrhagic septicaemia. In addition, exploration of the cerebrospinal fluid during infection has never been studied before. Therefore, this study was designed to fill up the grey areas in haemorrhagic septicaemia research. Twenty-one buffalo calves were divided into seven treatment groups where group 1 was inoculated orally with 10 mL of sterile phosphate-buffered saline pH 7 which act as a negative control group. Groups 2 and 3 were inoculated orally and subcutaneously with 10 mL of 1012 colony-forming unit of P. multocida type B:2. Group 4 and 5 buffaloes were inoculated orally and intravenously with 10 mL of lipopolysaccharide broth. Groups 6 and 7 were administered orally and subcutaneously with 10 mL of outer membrane protein broth. During the post-infection period of 21 days, blood and cerebrospinal fluid were sampled for the analyses of pro-inflammatory cytokines, acute phase proteins and cytological examination. Buffalo calves infected with P. multocida and its immunogens via different routes of inoculation showed significant changes (p 
  8. Jesse FF, Ibrahim HH, Abba Y, Chung EL, Marza AD, Mazlan M, et al.
    BMC Vet Res, 2017 Apr 05;13(1):88.
    PMID: 28381248 DOI: 10.1186/s12917-017-1010-y
    BACKGROUND: Hemorrhagic septicemia is a fatal disease of cattle and buffaloes caused by P. multocida. Although the pathogenesis of the bacteria has been well established in literature, there is a paucity of information on the possible role of the bacteria and its immunogens; lipopolysaccharide (LPS) and outer membrane proteins (OMPs) on the reproductive capacity of buffalo heifers.

    METHODS: In this study, twenty one healthy prepubertal female buffaloes aged 8 months were divided into seven groups of 3 buffaloes each (G1-G7). Group 1 (G1) served as the negative control group and were inoculated orally with 10 mL sterile Phosphate Buffer Saline (PBS), groups 2 (G2) and 3 (G3) were inoculated orally and subcutaneously with 10 mL of 10(12) colony forming unit (cfu) of P.multocida type B: 2, while groups 4 (G4) and 5 (G5) received 10 mL of bacterial LPS orally and intravenously, respectively. Lastly, groups 6 (G6) and 7 (G7) were orally and subcutaneously inoculated with 10 mL of bacterial OMPs. Whole blood was collected in EDTA vials at stipulated time points (0, 2, 4, 6, 8, 10, 12, 24, 36, 48, 72, 120, 168, 216, 264, 312, 360, 408, 456 and 504 h), while tissue sections of the pituitary glands were collected and transported to the histopathology laboratory in 10% buffered formalin for processing and Hematoxylin and eosin staining. Plasma levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), progesterone (PG), estradiol (EST) and gonadotrophin releasing hormone (GnRH) were determined.

    RESULTS: The histopathological lesions observed in the pituitary gland included hemorrhage, congestion, inflammatory cell infiltration, hydropic degeneration, necrosis and edema. These changes were higher (p 

  9. Marza AD, Jesse Abdullah FF, Ahmed IM, Teik Chung EL, Ibrahim HH, Zamri-Saad M, et al.
    Microb Pathog, 2017 Mar;104:340-347.
    PMID: 28126667 DOI: 10.1016/j.micpath.2017.01.031
    Lipopolysaccharide (LPS) of P. multocida B:2, a causative agent of haemorrhagic septicaemia (HS) in cattle and buffaloes, is considered as the main virulence factor and contribute in the pathogenesis of the disease. Recent studies provided evidences about the involvement of the nervous system in pathogenesis of HS. However, the role of P. multocida B:2 immunogens, especially the LPS is still uncovered. Therefore, this study was designed to investigate the role of P. multocida B:2 LPS to induce pathological changes in the nervous system. Nine eight-month-old, clinically healthy buffalo calves were used and distributed into three groups. Calves of Group 1 and 2 were inoculated orally and intravenously with 10 ml of LPS broth extract represent 1 × 10(12) cfu/ml of P. multocida B:2, respectively, while calves of Group 3 were inoculated orally with 10 ml of phosphate buffer saline as a control. Significant differences were found in the mean scores for clinical signs, post mortem and histopathological changes especially in Group 2, which mainly affect different anatomic regions of the nervous system, mainly the brain. On the other hand, lower scores have been recorded for clinical signs, gross and histopathological changes in Group 1. These results provide for the first time strong evidence about the ability of P. multocida B:2 LPS to cross the blood brain barrier and induce pathological changes in the nervous system of the affected buffalo calves.
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links